Literature DB >> 23525677

Tubulocystic carcinoma of the kidney: a histologic, immunohistochemical, and ultrastructural study.

Borislav A Alexiev1, Cinthia B Drachenberg.   

Abstract

Tubulocystic carcinoma of the kidney (TCCK) is a tumor entity, which is not yet included in the WHO classification of renal tumors. The histogenesis of this neoplasm is uncertain. This study was undertaken to determine (1) the incidence of TCCK and (2) immunohistochemical and ultrastructural characteristics of those tumors that qualify as TCCK by the current definitions. From January 1, 2003 to December 31, 2012, a total of 615 renal cell carcinomas (RCCs) were seen by the Department of Pathology, University of Maryland Medical Center. Four TCCKs were identified (4/615, <1 %). TCCK is a distinctive group of kidney tumors with a male predominance and noteworthy macroscopic spongy appearance. Microscopically, the tumors were composed of tubules and cysts lined by a single layer of eosinophilic, columnar, cuboidal, flat, or hobnail cells with large nuclei and prominent nucleoli separated by a thin fibrotic stroma. In all TCCKs, the majority of neoplastic cells showed immunohistochemical (CD10(+), RCC(+), vimentin(+), and AMACR(+)) and ultrastructural (abundant long brush border microvilli) characteristics of proximal renal tubules. In few cells, the microvilli were shorter and sparse with cytoplasmic interdigitation analogous to intercalated cells of the collecting ducts. Focal positivity for BerEP4 (a marker preferentially expressed in distal renal tubules) was also noted. The major differential diagnostic considerations are oncocytoma, multilocular cystic renal cell carcinoma, and cystic nephroma/mixed epithelial and stromal tumor of the kidney. TCCK seems to have a favorable prognosis. In the current series, none of the patients had local recurrence or metastatic disease.

Entities:  

Mesh:

Year:  2013        PMID: 23525677     DOI: 10.1007/s00428-013-1398-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  22 in total

1.  Renal oncocytoma: a clinicopathologic study of 70 cases.

Authors:  B Perez-Ordonez; G Hamed; S Campbell; R A Erlandson; P Russo; P B Gaudin; V E Reuter
Journal:  Am J Surg Pathol       Date:  1997-08       Impact factor: 6.394

Review 2.  Tubulocystic carcinoma, mucinous tubular and spindle cell carcinoma, and other recently described rare renal tumors.

Authors:  Gregory T MacLennan; David G Bostwick
Journal:  Clin Lab Med       Date:  2005-06       Impact factor: 1.935

3.  Expression of segment-specific antigens in the human nephron and in renal epithelial tumors.

Authors:  P Holm-Nielsen; G Pallesen
Journal:  APMIS Suppl       Date:  1988

4.  The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.

Authors:  C-C Pan; P C-H Chen; D M-T Ho
Journal:  Histopathology       Date:  2004-11       Impact factor: 5.087

Review 5.  Immunohistochemical and lectin dissection of the human nephron in health and disease.

Authors:  F G Silva; T Nadasdy; Z Laszik
Journal:  Arch Pathol Lab Med       Date:  1993-12       Impact factor: 5.534

6.  Tubulocystic carcinoma of the kidney: a new entity among renal tumors.

Authors:  Sandy Azoulay; Annick Vieillefond; François Paraf; Dominique Pasquier; Olivier Cussenot; Patrice Callard; Mathilde Sibony
Journal:  Virchows Arch       Date:  2007-09-05       Impact factor: 4.064

7.  Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney are the same disease entity: molecular and histologic evidence.

Authors:  Ming Zhou; Eric Kort; Philip Hoekstra; Michael Westphal; Cristina Magi-Galluzzi; Linda Sercia; Brian Lane; Brian Rini; Ronald Bukowski; Bin T Teh
Journal:  Am J Surg Pathol       Date:  2009-01       Impact factor: 6.394

8.  Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma.

Authors:  Mahul B Amin; Gregory T MacLennan; Ruta Gupta; David Grignon; Francois Paraf; Annick Vieillefond; Gladell P Paner; Mark Stovsky; Andrew N Young; John R Srigley; John C Cheville
Journal:  Am J Surg Pathol       Date:  2009-03       Impact factor: 6.394

9.  Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization.

Authors:  Ximing J Yang; Ming Zhou; Ondrej Hes; Steven Shen; Rongshan Li; Jose Lopez; Rajal B Shah; Yu Yang; Shang-Tian Chuang; Fan Lin; Maria M Tretiakova; Eric J Kort; Bin Tean Teh
Journal:  Am J Surg Pathol       Date:  2008-02       Impact factor: 6.394

10.  Cystic nephroma and mixed epithelial and stromal tumor of kidney: a detailed clinicopathologic analysis of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a unifying term.

Authors:  Julia Turbiner; Mahul B Amin; Peter A Humphrey; John R Srigley; Laurence De Leval; Anuradha Radhakrishnan; Esther Oliva
Journal:  Am J Surg Pathol       Date:  2007-04       Impact factor: 6.394

View more
  10 in total

Review 1.  Diagnostic approach to eosinophilic renal neoplasms.

Authors:  Oleksandr N Kryvenko; Merce Jorda; Pedram Argani; Jonathan I Epstein
Journal:  Arch Pathol Lab Med       Date:  2014-11       Impact factor: 5.534

2.  Tubulocystic Renal Cell Carcinoma: A Great Imitator.

Authors:  Indraneel Banerjee; Sher Singh Yadav; Vinay Tomar; Suresh Yadav; Shyam Talreja
Journal:  Rev Urol       Date:  2016

3.  Tubulocystic renal cell carcinoma: Report of a rare case.

Authors:  Aanchal Kakkar; Mehar C Sharma; Manpreet Uppal; Sunil Chumber
Journal:  Can Urol Assoc J       Date:  2015-09-09       Impact factor: 1.862

4.  Tubulocystic carcinoma of the kidney.

Authors:  Varsha Podduturi; Carol F Adair; Haiying Zhang
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-07

5.  Tubulocystic Renal Cell Carcinoma: An Underrecognized Clinicopathologic Entity.

Authors:  Sudeep Khera; Poonam Elhence; Taruna Yadav; Himanshu Pandey
Journal:  Ochsner J       Date:  2022

Review 6.  Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: clinicopathologic study of two cases and review of the literature.

Authors:  Ming Zhao; Xiaodong Teng; Guoqing Ru; Zhongsheng Zhao; Qinqin Hu; Likai Han; Xianglei He
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  Uretheral invagination of multilocular cystic nephroma; a case report of a new pathologic variant.

Authors:  Hakan Ozturk; Serap Karaaslan
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

8.  New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

Authors:  Kiril Trpkov; Ondrej Hes; Sean R Williamson; Anthony J Gill; Adebowale J Adeniran; Abbas Agaimy; Reza Alaghehbandan; Mahul B Amin; Pedram Argani; Ying-Bei Chen; Liang Cheng; Jonathan I Epstein; John C Cheville; Eva Comperat; Isabela Werneck da Cunha; Jennifer B Gordetsky; Sounak Gupta; Huiying He; Michelle S Hirsch; Peter A Humphrey; Payal Kapur; Fumiyoshi Kojima; Jose I Lopez; Fiona Maclean; Cristina Magi-Galluzzi; Jesse K McKenney; Rohit Mehra; Santosh Menon; George J Netto; Christopher G Przybycin; Priya Rao; Qiu Rao; Victor E Reuter; Rola M Saleeb; Rajal B Shah; Steven C Smith; Satish Tickoo; Maria S Tretiakova; Lawrence True; Virginie Verkarre; Sara E Wobker; Ming Zhou
Journal:  Mod Pathol       Date:  2021-03-04       Impact factor: 8.209

9.  Tubulocystic Renal Cell Carcinoma: A Rare Renal Tumor.

Authors:  Jasneet Singh Bhullar; Sandiya Bindroo; Neha Varshney; Vijay Mittal
Journal:  J Kidney Cancer VHL       Date:  2014-09-01

Review 10.  Tubulocystic renal cell carcinoma in the left kidney: a case report.

Authors:  Yusuke Ishibashi; Takuya Koie; Naoki Fujita; Tendo Satoh; Jotaro Mikami; Shingo Hatakeyama; Chikara Ohyama; Yuki Tobisawa; Tohru Yoneyama
Journal:  J Med Case Rep       Date:  2014-07-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.